Phase 3 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The main brain tumour being treated must be no larger than 4 cm (for single-session treatment) or 7 cm (for multi-session treatment) before surgery
- A person must be considered a suitable candidate for a type of targeted brain radiation (called SRS) within 30 days before or after surgical removal of the tumour, as confirmed by a doctor's assessment or a specialist brain tumour team review
- A person must have a reasonably good level of physical functioning, as measured by standard medical scoring tools, within 30 days of joining the trial (confirm with trial site for exact score requirements)
- A person must agree to be randomly assigned to a treatment group, confirmed by signing an approved consent form
- There must be no signs on brain scans that the cancer has spread to the lining of the brain or spinal cord, as confirmed by a specialist radiologist review
- A person must have a documented history of cancer (a confirmed cancer diagnosis on record)
Who may not be able to join:
- People who have previously received any radiation treatment to the brain for any reason
- People whose primary (original) cancer is small-cell lung cancer, lymphoma, leukaemia, or multiple myeloma
- People who are pregnant or currently breastfeeding (this is because a contrast dye used in scans may carry risks during pregnancy)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Debra N Yeboa, M.D. Anderson Cancer Center
Phone: 713-563-2300
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Leptomeningeal disease (LMD)-free rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.